Syra Health Corp. reported a revenue of approximately $7.2 million for the fiscal year ending December 31, 2025, a decrease of 9% from $8.0 million in 2024. The decline in revenue was primarily attributed to a significant drop in healthcare workforce services, which fell from $5.9 million in 2024 to $1.9 million in 2025. This reduction was due to fewer new customer acquisitions and lower renewal values on key contracts. In contrast, revenue from population health management services increased to $5.3 million, up from $2.1 million the previous year, reflecting additional services provided to state health departments. The company reported a net loss of $896,333 for 2025, a substantial improvement compared to a net loss of $3.8 million in 2024.
Operationally, Syra Health has made strategic changes, including the launch of its flagship product, Syrenity, a mental health application designed to provide preventative care and interventions. This product is expected to enhance user engagement through an AI-driven user diary and virtual consultations with licensed mental health professionals. The company also aims to expand its services geographically and is exploring potential acquisitions to strengthen its service offerings. As of March 4, 2026, Syra Health employed 38 full-time and 51 part-time employees, reflecting a strategic focus on streamlining operations and reducing redundancies.
The company’s financial position showed a cash balance of $1.6 million as of December 31, 2025, down from $2.4 million in 2024. Current liabilities increased slightly to $674,739, while working capital decreased to $2.1 million. The accumulated deficit rose to $9.7 million, raising concerns about the company's ability to continue as a going concern without additional funding. The independent registered public accounting firm expressed substantial doubt about the company's ability to continue operations, highlighting the need for further capital to sustain business activities.
Looking ahead, Syra Health is focused on enhancing its sales force productivity and cross-selling its solutions to existing customers. The company is also preparing for the launch of Syrenity in global markets and aims to participate in government healthcare projects. However, the company faces challenges, including potential delays in contract awards and cancellations due to federal budget reviews. The management remains optimistic about future growth, contingent on securing additional funding and successfully executing its strategic initiatives.
About Syra Health Corp
Syra Health Corp. is a healthcare services provider focused on preventative health, behavioral and mental health, population health, digital health, health education, and workforce solutions. It develops patient-centric, technology-enabled solutions, including AI-driven mental health apps and data analytics, serving payers, providers, government agencies, and academic institutions. The company emphasizes health equity, access, and innovative approaches to improve health outcomes and reduce disparities.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.